<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02725944</url>
  </required_header>
  <id_info>
    <org_study_id>2014/1260 D (REK)</org_study_id>
    <nct_id>NCT02725944</nct_id>
  </id_info>
  <brief_title>Prediction and Detection of Occult Atrial Fibrillation in Patients After Acute Cryptogenic Stroke and TIA</brief_title>
  <acronym>PROACTIA</acronym>
  <official_title>Prediction and Detection of Occult Atrial Fibrillation in Patients After Acute Cryptogenic Stroke and Transient Ischemic Attack</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Akershus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Akershus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      PROACTIA is a prospective, event-driven observational study. It aims to propose a composite
      scoring system in order to evaluate the risk of paroxysmal atrial fibrillation (PAF) in
      patients after acute cryptogenic stroke and transient ischemic attack (TIA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It will be enrolled 250 participants of both sexes within two weeks after diagnosed
      cryptogenic stroke and/or TIA at Akershus University Hospital, Oslo area, Norway.

      Evaluation of participants' comorbidity with CHADS2-VASc score, ECG, Holter ECG,
      echocardiography, detection of biochemical cardiac markers and screening for obstructive
      sleep apnea syndrome will be performed. All participants will be monitored with a continuous
      cardiac rhythm during one year by implantation of implantable cardiac rhythm monitors (ICRM).
      All patients without high bleeding risk will get prescribed oral anticoagulants (OAC) after
      detection of PAF.

      A biobank will be established in order to store the sampled biological material.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Detection of paroxysmal atrial fibrillation</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Cerebrovascular Stroke</condition>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Patients with cryptogenic stroke and TIA</arm_group_label>
    <description>Implantation of ICRM in all participants.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantation of ICRM</intervention_name>
    <description>All patients will be implanted with ICRM in order to detect an occult PAF.</description>
    <arm_group_label>Patients with cryptogenic stroke and TIA</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        250 participants of both sexes included at Akershus University Hospital, Norway, within two
        weeks after diagnosed with cryptogenic stroke and/or TIA.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Patients diagnosed with cryptogenic stroke and/or TIA, in accordance to the TOAST (Trial
        of Org 10172 in Acute Stroke Treatment) classification.

        Exclusion Criteria:

          -  Patients with known or newly detected AF on initial examination including 24 h Holter
             ECG.

          -  Patients on oral anticoagulants (OAC) for non-AF indications.

          -  Patients with strong contraindications for OAC, even if the presence of underlying AF
             is detected.

          -  Patients with atrial- or ventricular thrombi, or atheromas of the aortic arch greater
             than 4 mm, detected by transesophageal echocardiography.

          -  Patients unable to sign the informed consent or with a life expectancy due to
             comorbidities of less than two years.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kjetil Steine, MD, PhD, ass.professor</last_name>
    <phone>+4799585554</phone>
    <email>kjetil.steine@uio.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Harald Kjekshus, MD, PhD</last_name>
    <phone>+4791713821</phone>
    <email>harald.kjekshus@ahus.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Loreta Skrebelyte-Strøm</name>
      <address>
        <city>Oslo</city>
        <state>Akershus</state>
        <zip>1478</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loreta Skrebelyte-Strøm, MD</last_name>
      <phone>+4792449186</phone>
      <email>lors@ahus.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2016</study_first_submitted>
  <study_first_submitted_qc>March 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2016</study_first_posted>
  <last_update_submitted>January 8, 2018</last_update_submitted>
  <last_update_submitted_qc>January 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Akershus</investigator_affiliation>
    <investigator_full_name>Loreta Skrebelyte-Strøm, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Cryptogenic stroke</keyword>
  <keyword>Occult paroxysmal atrial fibrillation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

